Stryker SYK
NYSE SYK
$275.50 -0.93 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026)

Stryker's (SYK) quarterly Liabilities and Shareholders Equity came in at $47.9 billion in Q2 2026, up 3.45% year-over-year from $46.3 billion in Q2 2025, and up 3.54% quarter-over-quarter from $46.3 billion in Q1 2026.

Analysis

Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Stryker (SYK) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $47.9 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 3.45% year-over-year to $47.9 billion in Q2 2026; TTM through Jun 2026 was $189.1 billion, a 5.57% increase from a year earlier, with the FY2025 full-year figure at $47.8 billion, up 11.34% from the prior year.
  • Liabilities and Shareholders Equity was $47.9 billion for Q2 2026 at Stryker, up from $46.3 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $47.9 billion in Q2 2026 and troughed at $36.0 billion in Q3 2022.
  • A 5-year average of $41.3 billion and a median of $39.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity rose 18.4% in 2025 and climbed 0.62% in 2026, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $36.9 billion in 2022, then advanced by 8.21% to $39.9 billion in 2023, then gained by 7.66% to $43.0 billion in 2024, then rose by 11.34% to $47.8 billion in 2025, then climbed by 0.18% to $47.9 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $47.9 billion (Q2 2026), $46.3 billion (Q1 2026), and $47.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 93.31 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 13.87 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 6.46 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 10.74 Bn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 22.80 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.93 Bn
Mar 31, 2026 46.29 Bn
Dec 31, 2025 47.84 Bn
Sep 30, 2025 47.06 Bn
Jun 30, 2025 46.33 Bn
Mar 31, 2025 46.01 Bn
Dec 31, 2024 42.97 Bn
Sep 30, 2024 43.83 Bn
Jun 30, 2024 39.13 Bn
Mar 31, 2024 39.40 Bn
Dec 31, 2023 39.91 Bn
Sep 30, 2023 38.04 Bn
Jun 30, 2023 37.41 Bn
Mar 31, 2023 36.83 Bn
Dec 31, 2022 36.88 Bn
Sep 30, 2022 35.98 Bn
Jun 30, 2022 36.03 Bn
Mar 31, 2022 36.14 Bn
Dec 31, 2021 34.63 Bn
Sep 30, 2021 34.15 Bn